Compare AU
Compare DRUG vs. RCAP
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Resolution Cap Global Prop Sec (Managed Fund) (RCAP). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | RCAP | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 3 |
Median incremental investment | $967.00 | $6,993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $10,243.09 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | RCAP | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | RCAP.AX was created on 2022-02-22 by Resolution Capital. The fund's investment portfolio concentrates primarily on real estate equity. The Fund aims to achieve an annual total return that exceeds the total return of the Benchmark after fees on a rolling 3 year basis |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | Welltower Inc (8.93 %) Equinix Inc (6.60 %) Ventas Inc (6.50 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Real Estate (100.00 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (60.84 %) United Kingdom of Great Britain and Northern Ireland (11.25 %) France (6.53 %) |
Management fee | 0.57 % | 0.8 % |
Key Summary
DRUG | RCAP | |
|---|---|---|
Issuer | BetaShares | Resolution Capital |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.8 % |
Price | $8.25 | $1.69 |
Size | $182.401 million | N/A |
10Y return | N/A | 16.56 % |
Annual distribution yield (5Y) | 1.90 % | 1.59 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 21/02/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | RCAP | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 3 |
Median incremental investment | $967.00 | $6,993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $10,243.09 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | RCAP | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | RCAP |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |